IRIS
PASSARIELLO, MARGHERITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 385
EU - Europa 303
AS - Asia 120
AF - Africa 16
SA - Sud America 2
OC - Oceania 1
Totale 827
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 378
IT - Italia 222
SG - Singapore 68
NL - Olanda 48
CN - Cina 30
IN - India 20
CI - Costa d'Avorio 15
FI - Finlandia 9
CA - Canada 6
GB - Regno Unito 5
SE - Svezia 5
DE - Germania 4
IE - Irlanda 4
BR - Brasile 2
AU - Australia 1
BE - Belgio 1
ES - Italia 1
FR - Francia 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 827
Salva come PNG Salva come JPEG
Città #
Naples 108
Chandler 78
Singapore 56
Amsterdam 47
Ashburn 45
Napoli 24
Pune 18
Santa Clara 18
Lawrence 17
Beijing 16
Boston 16
Ercolano 14
Des Moines 10
Millbury 10
Helsinki 6
Acerra 5
Seattle 5
Wilmington 5
Los Angeles 4
Marano di Napoli 4
Nanjing 4
Casavatore 3
Caserta 3
Dallas 3
Toronto 3
Trentola-Ducenta 3
Bernalda 2
Dublin 2
Formia 2
Houston 2
Indore 2
Ischia 2
Kronberg 2
Lappeenranta 2
Marano 2
Marcianise 2
Princeton 2
Quartu Sant'elena 2
Rome 2
Shanghai 2
São Paulo 2
Afragola 1
Aprilia 1
Arezzo 1
Augusta 1
Belgrade 1
Brussels 1
Chicago 1
Clifton 1
Fairfield 1
Frankfurt am Main 1
Guangzhou 1
Hebei 1
Islamabad 1
Jiaxing 1
London 1
Milan 1
Misterbianco 1
Mugnano di Napoli 1
Munich 1
Nola 1
Norwalk 1
Ottawa 1
Panama City 1
Pinerolo 1
Portici 1
Pozzuoli 1
San Giorgio a Cremano 1
Shijiazhuang 1
Silea 1
Sydney 1
Utrecht 1
Vientiane 1
Washington 1
Winnipeg 1
Wuhan 1
Wynberg 1
Totale 591
Salva come PNG Salva come JPEG
Nome #
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2 47
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries 45
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 44
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. 43
A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells 42
Long-chain polyphosphates impair SARS-CoV-2 infection and replication 42
Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells. 39
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model 37
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells 36
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab 35
Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell Killing 35
Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes 35
Novel combinations of human immunomodulatory mAbs lacking cardiotoxic effects for therapy of TNBC 34
Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab 33
Interactions of spike‐rbd of sars‐cov‐2 and platelet factor 4: New insights in the etiopathogenesis of thrombosis 32
T-cell Activating Tribodies as a Novel Approach for Efficient Killing of ErbB2-positive Cancer Cells. 31
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand 29
Superior Suppression of ErbB2-positive Tumor Cells by a Novel Human Triparatopic Tribody 28
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling 23
Immunomodulatory mabs as tools to investigate on cis-interaction of pd-1/pd-l1 on tumor cells and to set up methods for early screening of safe and potent combinatorial treatments 23
Evidences of CTLA-4 and PD-1 blocking agents-induced cardiotoxicity in cellular and preclinical models 22
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC 21
Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo 19
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology 19
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 18
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy 16
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways 16
A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies 14
HUMAN ANTI-FV ANTIBODY, THERAPEUTIC AND DIAGNOSTIC APPLICATIONS THEREOF 14
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma 13
Fusion proteins 12
Totale 897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 2 3 10 6 1
2020/202148 0 0 12 1 0 1 0 4 0 19 11 0
2021/2022145 0 4 1 1 1 4 16 9 10 21 41 37
2022/2023241 19 12 9 13 29 25 0 24 37 46 23 4
2023/2024234 10 28 52 21 9 39 10 25 0 2 23 15
2024/2025168 48 33 23 32 32 0 0 0 0 0 0 0
Totale 897